Lupin Limited (NSE:LUPIN)
India · Delayed Price · Currency is INR 2,265.00
-35.00 (-1.52%)
Aug 11, 2026, 1:00 PM IST
Lupin Employees
Lupin had 26,021 employees as of March 31, 2026. The number of employees increased by 2,015 or 8.39% compared to the previous year.
Employees
26,021
Change (1Y)
2,015
Growth (1Y)
8.39%
Revenue / Employee
11.52M INR
Profits / Employee
2.12M INR
Market Cap
1.04T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 26,021 | 2,015 | 8.39% |
| Mar 31, 2025 | 24,006 | 2,138 | 9.78% |
| Mar 31, 2024 | 21,868 | 935 | 4.47% |
| Mar 31, 2023 | 20,933 | 1,144 | 5.78% |
| Mar 31, 2022 | 19,789 | 1,216 | 6.55% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cipla | 31,369 |
| Zydus Lifesciences | 29,980 |
| Aurobindo Pharma | 29,209 |
| Mankind Pharma | 20,451 |
| Alkem Laboratories | 19,346 |
| Ipca Laboratories | 17,210 |
| Glenmark Pharmaceuticals | 15,800 |
| Divi's Laboratories | 11,565 |
Lupin News
- 3 days ago - Lupin Transcript: Q1 26/27 - Transcripts
- 3 days ago - Lupin Quarterly report: Q1 2027 - Filings
- 3 days ago - Lupin Slides: Q1 2027 - Filings
- 20 days ago - Lupin Transfers Two Oncology Assets To Kaveri Therapeutics - Nasdaq
- 5 weeks ago - Lupin receives EIR from U.S. FDA for Somerset facility with VAI classification - Business Upturn
- 5 weeks ago - Lupin receives EMA approval for NaMuscla expansion for paediatric use - Business Upturn
- 6 weeks ago - Lupin Gets Tentative FDA Nod For Enzalutamide Tablets - Nasdaq
- 6 weeks ago - Lupin Wins FDA's Tentative Approval For Enzalutamide Tablets Across Multiple Strengths - Nasdaq